Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)

NCT04327401 is registered in ClinicalTrials.gov with Hospital Sirio-Libanes as lead sponsor.

NCT NCT04327401
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04327401 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19-associated ARDS Treated With DEXamethasone: an Open-label, Randomized, Controlled Trial: CoDEX (Alliance Covid-19 Brasil III)
Lead sponsor
Hospital Sirio-Libanes
Phase
Phase 3
Overall status
Terminated
Start date
April 13, 2020
Completion date
July 22, 2020
Enrollment
299 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, coronavirus infection, pneumonia, viral